Successful weight reduction improves left ventricular diastolic function and physical performance in severe obesity

International Heart Journal
S FenkA Baessler

Abstract

Obesity and the metabolic syndrome (MetS) are risk factors for left ventricular diastolic dysfunction (LVDD). However, little is known about the impact of successful weight reduction (WR) on diastolic function and physical performance.Obese subjects (øBMI 40.2 ± 8.6 kg/m(2)) underwent a 1-year WR program comprising diet and lifestyle components. Echocardiography and exercise capacity (6-minute walk) were performed at baseline and after 1 year. The distribution of weight reduction was split at the sample median and subjects were dichotomized in "successful WR" (% WR ≥ median, corresponding to a weight loss of 8%) and "failed-WR" (% WR < median).From a total of 188 obese subjects, 71 had LVDD at baseline. Obese patients with successful WR improved their MetS alterations, including fasting glucose, insulin, lipids, adipokines, blood pressure levels, and epicardial fat thickness. The same was not true for obesity with failed WR. Subjects with successful WR demonstrated significant improvement in echocardiographic LVDD parameters (median [interquartile range]): Δe' (2,5 [-1.0, 4.7], P < 0.01), Δe'/a' (0.34 [0.07, 079], P < 0.01), ΔE/e' (-1.14 [-2.72, -0.54], P < 0.05), ΔE/A (0.08 [-0.04, 0.26], P < 0.05), ΔArd-Ad (-28 [-54, -4], P <...Continue Reading

References

Dec 1, 1995·The American Journal of Cardiology·M A AlpertV Mukerji
Dec 1, 1995·Journal of the American College of Cardiology·R S VasanD Levy
Oct 8, 1999·The New England Journal of Medicine·E E CalleC W Heath
Sep 18, 2001·JAMA : the Journal of the American Medical Association·A H MokdadJ P Koplan
Aug 2, 2002·The New England Journal of Medicine·Satish KenchaiahRamachandran S Vasan
Apr 20, 2004·Journal of the American College of Cardiology·Linda R PetersonVíctor G Dávila-Román
May 7, 2004·The New England Journal of Medicine·Michael R ZileWilliam H Gaasch
Jun 15, 2004·The American Journal of Cardiology·Maria E OttoVirend Somers
Nov 3, 2004·Circulation·Robert H EckelUNKNOWN American Heart Association
Jun 14, 2005·The American Journal of Cardiology·Howard J WillensMaureen H Lowery
Sep 28, 2005·Nature Clinical Practice. Cardiovascular Medicine·Gianluca IacobellisArya M Sharma
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jul 27, 2007·Nature Clinical Practice. Cardiovascular Medicine·Chiew Wong, Thomas H Marwick
Nov 14, 2008·The New England Journal of Medicine·T PischonE Riboli
Feb 4, 2009·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Sherif F NaguehArturo Evangelista
Mar 10, 2009·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Sherif F NaguehArturo Evangelisa
Mar 20, 2009·The New England Journal of Medicine·Kirsten Bibbins-DomingoStephen B Hulley
Aug 15, 2009·Journal of the American College of Cardiology·Oliver J RiderStefan Neubauer
Dec 1, 2009·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Gianluca Iacobellis, Howard J Willens
Oct 12, 2010·JAMA : the Journal of the American Medical Association·Bret H GoodpasterJohn M Jakicic
Nov 7, 2012·Journal of Consulting and Clinical Psychology·Daniel S Kirschenbaum, Kristen Gierut
Dec 28, 2012·The International Journal of Cardiovascular Imaging·O J RiderS Neubauer
Feb 16, 2013·The American Journal of Medicine·Jessica L UnickUNKNOWN Look AHEAD Research Group

❮ Previous
Next ❯

Citations

Dec 1, 2015·Expert Opinion on Therapeutic Targets·Andrew Jm LewisOliver J Rider
Jul 18, 2015·Progress in Cardiovascular Diseases·Arthur R MenezesFreddy M Abi-Samra
Jun 9, 2016·Korean Circulation Journal·JinShil KimMi-Seung Shin
Aug 3, 2016·Korean Circulation Journal·Shin Yi JangSang-Chol Lee
Oct 16, 2016·Journal of the American College of Cardiology·Jeffrey I MechanickW Timothy Garvey
Oct 21, 2016·Cardiovascular Drugs and Therapy·Catarina FranciscoAdelino Leite-Moreira
Dec 24, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tae-Min RheeMyung-A Kim
Feb 10, 2020·Lipids in Health and Disease·Yu Si YaoZhi Huan Zeng
Feb 7, 2018·Sudebno-meditsinskaia ekspertiza·Yu I PigolkinD V Gornostaev
Oct 1, 2021·Lipids in Health and Disease·Xunwei DengZhixiong Zhong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.